p53, p21(WAF1/CIP1), and MDM2 involvement in proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells - PubMed (original) (raw)
p53, p21(WAF1/CIP1), and MDM2 involvement in proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells
J K Hsieh et al. Arterioscler Thromb Vasc Biol. 2000 Mar.
Abstract
Using an in vitro model of a conditionally immortalized cell line, we investigated how human vascular smooth muscle cells (VSMCs) are affected by the expression of simian virus 40 (SV40) large T antigen (LT antigen), which binds to cell cycle regulators, such as the tumor suppressor protein p53. Cells were obtained after infection of saphenous vein-derived VSMCs with a nonreplicative retroviral vector containing a temperature-sensitive (ts) mutant of SV40 LT antigen and were shown to have maintained some characteristics and responses of VSMCs. Under permissive temperature conditions (36 degrees C), the increased rate of cell proliferation was shown to be associated with expression of LT antigen and with LT-antigen binding to and inactivation of p53. p53 inactivation failed to block apoptosis induced by serum withdrawal or by UV irradiation. Downregulation of LT-antigen expression at the nonpermissive temperature (39 degrees C) was shown to be associated with growth arrest, increased expression of the cell cycle inhibitor p21(WAF1/CIP1), increased MDM2-promoter activity, and differential expression of MDM2 gene products, suggesting that p53-induced transcription/transactivation may be involved in VSMC cell cycle control but not necessarily apoptosis. The established SMC line HVTs-SM1 may be a useful model for the study of processes involved in myointimal hyperplasia and cellular aging, as well as for the study of cell cycle control in general.
Similar articles
- p53, p21(WAF1/CIP1), and MDM2 involvement in the proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells.
Hsieh JK, Kletsas D, Clunn G, Hughes AD, Schachter M, Demoliou-Mason C. Hsieh JK, et al. Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):973-81. doi: 10.1161/01.atv.20.4.973. Arterioscler Thromb Vasc Biol. 2000. PMID: 10764661 - The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents.
Gillet R, Grimber G, Bennoun M, Caron de Fromentel C, Briand P, Joulin V. Gillet R, et al. Oncogene. 2000 Jul 20;19(31):3498-507. doi: 10.1038/sj.onc.1203671. Oncogene. 2000. PMID: 10918608 - p53 expression in CMV-infected cells: association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2.
García JF, Piris MA, Lloret E, Orradre JL, Murillo PG, Martínez JC. García JF, et al. Histopathology. 1997 Feb;30(2):120-5. doi: 10.1046/j.1365-2559.1997.d01-577.x. Histopathology. 1997. PMID: 9067734 - Novel targets of Akt, p21(Cipl/WAF1), and MDM2.
Zhou BP, Hung MC. Zhou BP, et al. Semin Oncol. 2002 Jun;29(3 Suppl 11):62-70. doi: 10.1053/sonc.2002.34057. Semin Oncol. 2002. PMID: 12138399 Review. - Switching from life to death: the Miz-ing link between Myc and p53.
Vousden KH. Vousden KH. Cancer Cell. 2002 Nov;2(5):351-2. doi: 10.1016/s1535-6108(02)00186-1. Cancer Cell. 2002. PMID: 12450789 Review.
Cited by
- Cleavage of p53-vimentin complex enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of rheumatoid arthritis synovial fibroblasts.
Yang X, Wang J, Liu C, Grizzle WE, Yu S, Zhang S, Barnes S, Koopman WJ, Mountz JD, Kimberly RP, Zhang HG. Yang X, et al. Am J Pathol. 2005 Sep;167(3):705-19. doi: 10.1016/S0002-9440(10)62045-7. Am J Pathol. 2005. PMID: 16127151 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous